233 related articles for article (PubMed ID: 25736784)
1. MiRNAs in primary cutaneous lymphomas.
Yu X; Li Z; Liu J
Cell Prolif; 2015 Jun; 48(3):271-7. PubMed ID: 25736784
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in lung cancer progression.
Zhang WC; Liu J; Xu X; Wang G
Med Oncol; 2013; 30(3):675. PubMed ID: 23925663
[TBL] [Abstract][Full Text] [Related]
3. The role of miRNAs in cutaneous squamous cell carcinoma.
Yu X; Li Z
J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
[TBL] [Abstract][Full Text] [Related]
4. miRNAs as Key Players in the Management of Cutaneous Melanoma.
Lorusso C; De Summa S; Pinto R; Danza K; Tommasi S
Cells; 2020 Feb; 9(2):. PubMed ID: 32054078
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in cutaneous melanoma: Role as diagnostic and prognostic biomarkers.
Ross CL; Kaushik S; Valdes-Rodriguez R; Anvekar R
J Cell Physiol; 2018 Jul; 233(7):5133-5141. PubMed ID: 29226953
[TBL] [Abstract][Full Text] [Related]
6. LymphomiRs: microRNAs with regulatory roles in lymphomas.
Kozloski GA; Lossos IS
Curr Opin Hematol; 2015 Jul; 22(4):362-8. PubMed ID: 26049758
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
8. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.
Huang T; Zhou Y; Zhang J; Wong CC; Li W; Kwan JSH; Yang R; Chan AKY; Dong Y; Wu F; Zhang B; Cheung AHK; Wu WKK; Cheng ASL; Yu J; Wong N; Kang W; To KF
Oncogene; 2018 Mar; 37(9):1159-1174. PubMed ID: 29234151
[TBL] [Abstract][Full Text] [Related]
9. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in the thyroid.
Boufraqech M; Klubo-Gwiezdzinska J; Kebebew E
Best Pract Res Clin Endocrinol Metab; 2016 Oct; 30(5):603-619. PubMed ID: 27923454
[TBL] [Abstract][Full Text] [Related]
11. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
[TBL] [Abstract][Full Text] [Related]
12. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
Li X; Nie J; Mei Q; Han WD
World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
[TBL] [Abstract][Full Text] [Related]
15. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of miRNAs-cMYC circuits is a key event in refractory celiac disease type-2 lymphomagenesis.
Vaira V; Gaudioso G; Laginestra MA; Terrasi A; Agostinelli C; Bosari S; Di Sabatino A; Vanoli A; Paulli M; Ferrero S; Roncoroni L; Lombardo V; Perera LP; Fabris S; Vecchi M; Pileri S; Elli L
Clin Sci (Lond); 2020 May; 134(10):1151-1166. PubMed ID: 32420596
[TBL] [Abstract][Full Text] [Related]
17. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research.
Nariman-Saleh-Fam Z; Saadatian Z; Daraei A; Mansoori Y; Bastami M; Tavakkoli-Bazzaz J
Biomark Med; 2019 Feb; 13(2):147-159. PubMed ID: 30672305
[TBL] [Abstract][Full Text] [Related]
18. miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.
Solé C; Larrea E; Di Pinto G; Tellaetxe M; Lawrie CH
Cancer Lett; 2017 Oct; 405():79-89. PubMed ID: 28757417
[TBL] [Abstract][Full Text] [Related]
19. microRNA in Malignant Lymphoma.
Tagawa H
Adv Exp Med Biol; 2015; 889():41-50. PubMed ID: 26658995
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in lymphoid biology and disease.
Fabbri M; Croce CM
Curr Opin Hematol; 2011 Jul; 18(4):266-72. PubMed ID: 21519241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
